Home » Business News » 2011 » February » February 22, 2011

DSM announces new Supervisory Board chairman

February 22, 2011 - London

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that its Supervisory Board has appointed Rob Routs as its new chairman, succeeding Cor Herkströter.


Cor Herkströter has been a member of the DSM Supervisory Board since 1 April 2000 and its chairman since 12 March 2002. During his chairmanship DSM has transformed from a chemical company into a Life Sciences and Materials Sciences company. The leadership of DSM would like to express its deep gratitude to Cor Herkströter for his guidance and support in this process, which has now been successfully completed.

Rob Routs (64, Dutch nationality) held various positions at the Royal Dutch Shell group until his retirement at the end of 2008. His last positions were Executive Director Downstream and member of the Board of Directors of Royal Dutch Shell plc. He holds a Master's degree in Chemical Engineering and a PhD in Technical Sciences from Eindhoven University of Technology (Netherlands). Rob Routs has been a member of the Supervisory Board of DSM since April 2010.

The change of chairmanship of DSM's Supervisory Board will take place after the General Meeting of Shareholders to be held on 28 April 2011.

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about €8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information:


For more information:

DSM Corporate Communications

Herman Betten

tel. +31 (0) 45 5782017                   

fax +31 (0) 45 5740680                   


DSM Investor Relations

Hans Vossen

tel. +31 (0) 45 5782864

fax +31 (0) 10 4590275

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: DSM N.V. via Thomson Reuters ONE


Comment on this story